About GigaGen
GigaGen is a company based in San Francisco (United States) founded in 2011 was acquired by Grifols in March 2021.. GigaGen has raised $36.13 million across 19 funding rounds from investors including NIH, Grifols and HHS. The company has 36 employees as of December 31, 2022. GigaGen offers products and services including GIGA-564 and GIGA-2339. GigaGen operates in a competitive market with competitors including Sana Biotechnology, TScan Therapeutics, Janux Therapeutics, Carisma Therapeutics and Kronos Bio, among others.
- Headquarter San Francisco, United States
- Employees 36 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Gigagen Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of GigaGen
GigaGen offers a comprehensive portfolio of products and services, including GIGA-564 and GIGA-2339. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Targets CTLA-4 for treating advanced solid tumors with improved efficacy.
Therapy for Hepatitis B virus to neutralize infection and aid treatment.
Unlock access to complete
Funding Insights of GigaGen
GigaGen has successfully raised a total of $36.13M across 19 strategic funding rounds. The most recent funding activity was a Grant round of $3 million completed in January 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 19
- Last Round Grant — $3.0M
-
First Round
First Round
(03 Mar 2011)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2018 | Amount | Grant - GigaGen | Valuation |
investors |
|
| Jul, 2017 | Amount | Series B - GigaGen | Valuation |
investors |
|
| Jul, 2016 | Amount | Grant - GigaGen | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in GigaGen
GigaGen has secured backing from 6 investors, including institutional investors. Prominent investors backing the company include NIH, Grifols and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Drug discovery services are provided to the biopharma sector.
|
Founded Year | Domain | Location | |
|
A government-backed foundation providing seed-stage investments to support small businesses.
|
Founded Year | Domain | Location | |
|
Energy sources and policies are managed by the DOE.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by GigaGen
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - GigaGen
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Gigagen Comparisons
Competitors of GigaGen
GigaGen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sana Biotechnology, TScan Therapeutics, Janux Therapeutics, Carisma Therapeutics and Kronos Bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Genetically engineered cell therapies are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
T cell-based treatments for immunological and oncological disorders are developed.
|
|
| domain | founded_year | HQ Location |
Immunotherapeutics for cancer treatment are developed to target solid tumors.
|
|
| domain | founded_year | HQ Location |
Chimeric antigen receptor macrophages are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for cancer treatment are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Gigagen
Frequently Asked Questions about GigaGen
When was GigaGen founded?
GigaGen was founded in 2011.
Where is GigaGen located?
GigaGen is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Is GigaGen a funded company?
GigaGen is a funded company, having raised a total of $36.13M across 19 funding rounds to date. The company's 1st funding round was a Grant of $1.5M, raised on Mar 03, 2011.
How many employees does GigaGen have?
As of Dec 31, 2022, the latest employee count at GigaGen is 36.
What does GigaGen do?
Founded in 2011 and based in San Francisco, United States, GigaGen operates in the biotechnology sector. T-cell and antibody-based therapeutics are developed using a high-throughput platform that incorporates microfluidics, bioinformatics, next-generation sequencing, and genetic engineering. Full-length natively paired antibodies and T-cell receptors are produced from single primary B or T cells, with integration of clonal identity, function, and target binding data.
Who are the top competitors of GigaGen?
GigaGen's top competitors include Janux Therapeutics, Kronos Bio and Sana Biotechnology.
What products or services does GigaGen offer?
GigaGen offers GIGA-564 and GIGA-2339.
Who are GigaGen's investors?
GigaGen has 6 investors. Key investors include NIH, Grifols, HHS, DOE, and National Science Foundation.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.